Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Market Closed 02-14 16:00:00 EST

2.49

-0.12

-4.60%

盘后2.50

+0.01+0.40%

19:59 EST

High2.79	Low2.42	Vol1.50M
Open2.61	D1 Closing2.61	Amplitude14.18%
Mkt Cap15.60M	Tradable Cap14.36M	Total Shares6.27M
T/O4.12M	T/O Rate26.01%	Tradable Shares5.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":2.49,"timestamp":1739566800000,"preClose":2.61,"halted":0,"volume":1500126,"hourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.49,"latestTime":"19:59 EST","volume":22142,"amount":55002.5586,"timestamp":1739581164318},"delay":0,"floatShares":5767000,"shares":6266572,"eps":-18.911705,"marketStatus":"Market Closed","change":-0.12,"latestTime":"02-14 16:00:00 EST","open":2.61,"high":2.79,"low":2.42,"amount":4117113.2084616,"amplitude":0.141762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.911705,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":2.61,"preHourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.61,"latestTime":"09:27 EST","volume":376073,"amount":1071557.0588798,"timestamp":1739543270955},"postHourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.49,"latestTime":"19:59 EST","volume":22142,"amount":55002.5586,"timestamp":1739581164318},"volumeRatio":4.179445873731791,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX","defaultTab":"news","newsList":[{"id":"2511693089","title":"Evaxion Biotech (EVAX) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2511693089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511693089?lang=en_us&edition=fundamental","pubTime":"2025-02-14 22:05","pubTimestamp":1739541957,"startTime":"0","endTime":"0","summary":"Lake Street analyst Thomas Flaten maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of $6.00. The co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-lake-street-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-lake-street-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2511218698","title":"Evaxion Biotech Secures Nasdaq Compliance, Strengthens Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2511218698","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511218698?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:47","pubTimestamp":1739540846,"startTime":"0","endTime":"0","summary":"An announcement from Evaxion Biotech ( ($EVAX) ) is now available. On February 14, 2025, Evaxion Biotech announced that Nasdaq confirmed its full c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-secures-nasdaq-compliance-strengthens-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-secures-nasdaq-compliance-strengthens-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B64PRP62.GBP","TQQQ","PSQ",".IXIC","QID","IE00BKPKM429.USD","NVIW.SI","NQmain","IE00BGHQF748.EUR","MNQmain","BK4585","USJW.SI","QLD","SQQQ","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU2095319765.USD","EVAX","TSYW.SI","NDAQ","IE00B3QW5Z07.USD","BK4112","USAW.SI"],"gpt_icon":0},{"id":"2511660345","title":"BRIEF-Nasdaq Confirms Evaxion Is Fully Compliant, Withdraws Delisting Determination","url":"https://stock-news.laohu8.com/highlight/detail?id=2511660345","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511660345?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:12","pubTimestamp":1739538749,"startTime":"0","endTime":"0","summary":"BRIEF-Nasdaq Confirms Evaxion Is Fully Compliant, Withdraws Delisting DeterminationFeb 14 (Reuters) - Evaxion Biotech A/S EVAX.O:NASDAQ CONFIRMS EVAXION IS FULLY COMPLIANT, WITHDRAWS DELISTING DETERMI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nFWN3P5174:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2511667253","title":"Nasdaq Confirms Evaxion Is Fully Compliant, Withdraws Delisting Determination","url":"https://stock-news.laohu8.com/highlight/detail?id=2511667253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511667253?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:00","pubTimestamp":1739538014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nFWN3P5174:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2511667212","title":"Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination","url":"https://stock-news.laohu8.com/highlight/detail?id=2511667212","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511667212?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:00","pubTimestamp":1739538000,"startTime":"0","endTime":"0","summary":"Evaxion will remain listed on Nasdaq after successfully evidencing compliance with the Nasdaq minimum stockholders’ equity requirement. Evaxion has restored its equity above the minimum requirement through capital market activities. The conversion of Evaxion’s EIB loan to equity is still expected to be completed in Q1 2025, which is anticipated to further boost equity. “We are very pleased to have received formal confirmation that we are again fully compliant with Nasdaq’s rules and will remain listed as we always planned for. We thank Nasdaq for a constructive dialogue on the matter. Having significantly strengthened our equity and cash position, full focus is now on executing upon our strategy and pursuing our 2025 milestones”, says Christian Kanstrup, CEO of Evaxion.Evaxion remains in discussions with the European Investment Bank  about the conversion of 3.5 million out of Evaxion’s 7 million loan with EIB, which is expected to increase Evaxion’s equity by $3.7 million  immediately ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nasdaq-confirms-evaxion-fully-compliant-130000153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B3QW5Z07.USD","BK4139","LU2095319765.USD","LU2210150020.SGD","EVAX","PSQ","USJW.SI","TSYW.SI","QID","MNQmain","BK4585","NQmain","QLD","TQQQ","NVIW.SI","BK4588","LU2210149790.SGD","BK4112",".IXIC","USAW.SI","SQQQ","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BGHQF748.EUR"],"gpt_icon":1},{"id":"2511408522","title":"European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2511408522","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511408522?lang=en_us&edition=fundamental","pubTime":"2025-02-14 00:09","pubTimestamp":1739462951,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking slightly lower late Thursday morning, declining 0.04% to 1,402.70 on the S&P Europe Select ADR Index.From continental E","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","BK4599","BK4117","BTI.AU","UN","LU0689626769.HKD","LU1093756168.USD","BK4588","BK4551","BK4075","ULVR.UK","LU0889565916.HKD","ASND","BK4568","IE00BKVL7J92.USD","SAN.AU","AFG","TCBP","EVAX","NCNA","GRFS","LU0109394709.USD","BK4535","LU0320765992.SGD","BK4007","BK4020","BK4139","AMRN","LU0124676726.USD","BK4169","BK7142","NVO.AU","LU0154236417.USD","DEO","NOK","SLN","BCS","BNTX","BK4592","DGE.UK","SAN","BK4547","BK4548","BK4207","IE00BMPRXR70.SGD","NVO","BTI","BDRX","UL","BK4183"],"gpt_icon":1},{"id":"2510371469","title":"Evaxion Biotech Expands Capital Through ADS Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2510371469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510371469?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:27","pubTimestamp":1739366863,"startTime":"0","endTime":"0","summary":"An update from Evaxion Biotech ( ($EVAX) ) is now available. On January 31, 2025, Evaxion Biotech A/S closed a public offering of nearly 4 million ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-expands-capital-through-ads-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-expands-capital-through-ads-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2510395533","title":"European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2510395533","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510395533?lang=en_us&edition=fundamental","pubTime":"2025-02-12 00:04","pubTimestamp":1739289846,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.59% to 1,393.03 on the S&P Europe Select ADR Index.From continental Europe, the gainers we","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNN","BCS","BK7142","SLN","03143","SAP","ARGX","BDRX","BK1601","SQNS","LU0516422440.USD","BK4082","BK4077","00005","LU1481107354.HKD","LU0098860793.USD","SAN.AU","LU0516423091.SGD","LU0320765646.SGD","TRVG","LU0516422366.SGD","BK4588","SAN","LU1162221912.USD","BK1231","BK1572","BK4528","LU0417516738.SGD","HSBC","LU0109394709.USD","BK4023","CLLS","SHEL","LU0300736492.USD","BK4007","LU0889565916.HKD","BK4521","HSBA.UK","BBVA","HSHD.SI","LU0634319403.HKD","AKTX","BK4201","LU0164880469.USD","EVAX","LU0320765992.SGD","BCYC","LU0516422952.EUR","BK4141","AFG"],"gpt_icon":0},{"id":"2509235243","title":"EVAX Ups Cash to Further Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235243","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509235243?lang=en_us&edition=fundamental","pubTime":"2025-02-05 19:06","pubTimestamp":1738753560,"startTime":"0","endTime":"0","summary":"Evaxion  is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company's AI models, novel targets within days, rather than the traditional years it commonly takes with standard drug discovery methods. The use of AI also allows the company to decrease the risk of failure as the technology filters out those results that may result in low efficacy or unacceptable toxicity.Company management announced that it has completed a public offering of 3,997,361 of its American Depository Shares . The gross proceeds from the offering were $10.8 million, with just over $10 million going to the company after fees. We are pleased to see this successful offering that gives the company additional capital needed to further the exciting progress described below.We continue to be excited about the investment opportunities offered by EVAX. In","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/evax-ups-cash-further-research-110600918.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2509469070","title":"Evaxion Biotech Is Maintained at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2509469070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509469070?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:30","pubTimestamp":1738686600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2025 11:30 ET (16:30 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX"],"gpt_icon":0},{"id":"2509466683","title":"European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509466683?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:10","pubTimestamp":1738685450,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.50% to 1,356.26 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion Biotech , which soared 36.3%, followed by biopharmaceutical company DBV Technologies , which rose 10%. They were followed by financial services companies Banco Bilbao Vizcaya Argentaria  and Banco Santander , which were up 3.3% and 3.6%, respectively.The decliners from continental Europe were led by medical device maker EDAP TMS , which fell 1.2%, followed by consumer goods company Unilever  and pharmaceutical company Novo Nordisk , which were down 0.4% and 0.1% respectively.From the UK and Ireland, the gainers were led by Akari Therapeutics  and biopharmaceutical companies TC Biopharm , which rose 5.9% and 3.3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group  and Verona Pharma , which increased 2% and 1% respectively.The","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DBVT","SAN.AU","NVO.AU","BK4183","LU1093756325.SGD","BK4532","BK4588","VOD","BK4599","BK4007","BK4107","BK4117","BDRX","BK4139","BK4207","AKTX","AFG","BBVA","BK4592","BK4505","BK4521","VRNA","BK4132","IE00BZ1G4Q59.USD","TCBP","MREO","NCNA","SAN","EDAP","LU0124676726.USD","LU1093756168.USD","BK7142","LU0689626769.HKD","ULVR.UK","BK4082","BK4585","BK7104","EVAX","IE00BKVL7J92.USD","LU0154236417.USD","NVO"],"gpt_icon":1},{"id":"2508454936","title":"Evaxion Biotech (EVAX) Receives a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2508454936","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508454936?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:55","pubTimestamp":1738677316,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Evaxion Biotech (EVAX – Research Report), with a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-receives-a-buy-from-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-receives-a-buy-from-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2508451661","title":"Evaxion Biotech price target lowered to $6 from $35 at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2508451661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508451661?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:45","pubTimestamp":1738676735,"startTime":"0","endTime":"0","summary":"Lake Street lowered the firm’s price target on Evaxion Biotech (EVAX) to $6 from $35 and keeps a Buy rating on the shares after the company closed ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-price-target-lowered-to-6-from-35-at-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-price-target-lowered-to-6-from-35-at-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2508414771","title":"European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2508414771","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508414771?lang=en_us&edition=fundamental","pubTime":"2025-02-04 00:00","pubTimestamp":1738598455,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Monday morning, falling 1.0% to 1,351.08 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia , which rose 0.8%, followed by accommodations booking company trivago  and consumer goods giant Unilever , which were up 0.7% and 0.3% respectively.The decliners from continental Europe were led by biotech company Evaxion Biotech  and biopharmaceutical company DBV Technologies , which fell 7.9% and 4.3% respectively. They were followed by medical device maker EDAP TMS  and semiconductor company Sequans Communications , which were down 4% and 3% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics  and Verona Pharma , which increased 5.4% and 2.9% respectively. They were followed by pharmaceutical company Silence Therapeutics  and telecommunications operator Vodafone Group , which advanced 2.6% ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EDAP","DAVA","DBVT","UN","EVAX","BK4592","LU0689626769.HKD","BK4132","BK4020","TCBP","IE00BMPRXR70.SGD","LU0124676726.USD","AFG","BK4547","BK4139","NCNA","SLN","VOD","SQNS","BK4077","LU0648005311.SGD","LU0084288595.USD","TRVG","BK4117","BK4532","IE00BMPRXN33.USD","AKTX","BK4082","TRIB","VRNA","BK4585","DAVA.AU","BK4183","ULVR.UK","UL","BK4141","NOK","BK4134","BK4107","BK4007","BK4588"],"gpt_icon":0},{"id":"2508691847","title":"Evaxion Biotech Closes $10.8 Million Public Offering to Boost Vaccine Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2508691847","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508691847?lang=en_us&edition=fundamental","pubTime":"2025-02-01 05:47","pubTimestamp":1738360064,"startTime":"0","endTime":"0","summary":"Evaxion Biotech ( ($EVAX) ) has shared an announcement. On January 31, 2025, Evaxion Biotech A/S announced the successful closing of a $10.8 millio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-closes-10-8-million-public-offering-to-boost-vaccine-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-closes-10-8-million-public-offering-to-boost-vaccine-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2508997987","title":"Evaxion Announces Closing of $10.8 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2508997987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508997987?lang=en_us&edition=fundamental","pubTime":"2025-02-01 05:05","pubTimestamp":1738357500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nTUA4YZJSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2508096225","title":"European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2508096225","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508096225?lang=en_us&edition=fundamental","pubTime":"2025-02-01 00:18","pubTimestamp":1738340321,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.22% to 1,373.53 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking company trivago  and pharmaceutical company Ascendis Pharma , which rose 3.3% and 2.9% respectively.The decliners from continental Europe were led by telecommunications company Ericsson  and biotech firm Evaxion Biotech , which lost 2.1% and 2% respectively. They were followed by Banco Santander , which fell 1.6%.From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm  and Bicycle Therapeutics , which advanced 6.2% and 4.2% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group  and biotech firm Autolus Therapeutics , which rose 3.6% and 2.1% respectively.The decliners from the UK and Ireland included biopharmaceutical company Adaptimmune Therapeutics  cruise line operator Carnival , which lost ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SAN","BK4117","AUTL","BK4077","TCBP","BK4142","BK4515","BK4554","BK4139","BK4207","BCYC","BK7142","MREO","BK4020","BK4585","BK4505","CUK","ASND","AFG","SAN.AU","EVAX","LU0109394709.USD","TRVG","ERIC","ADAP","BK4591","BK4521","LU0889565916.HKD","LU0320765992.SGD","BK4107"],"gpt_icon":1},{"id":"2507679472","title":"BUZZ-Evaxion Biotech falls after pricing public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2507679472","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507679472?lang=en_us&edition=fundamental","pubTime":"2025-01-31 02:07","pubTimestamp":1738260433,"startTime":"0","endTime":"0","summary":"BUZZ-Evaxion Biotech falls after pricing public offering** Shares of biotech firm Evaxion Biotech EVAX.O fall 28.6% to $2.42 ** EVAX says it is raising $10.8 mln through public offering** EVAX is selling ~4 mln of its American Depositary Shares at $2.71/shr, along with warrants to buy additional shares** Offering priced at 20% discount to stock's last close** Funds will be used to advance EVAX's vaccine development pipeline and cover operating expenses, co says** EVAX has ~1.2 mln outstanding shares, with market cap of ~4 mln - LSEG data** Lake Street Capital Markets and Jones are acting as exclusive placement agents for offering** EVAX fell ~91% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nL3N3OQ1QT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","LU1571399168.USD","LU1699723380.USD","BK","BK4139","BK4585","BK4135","BK4559","BK4588"],"gpt_icon":1},{"id":"2507788956","title":"European Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2507788956","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507788956?lang=en_us&edition=fundamental","pubTime":"2025-01-31 00:11","pubTimestamp":1738253515,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were up sharply late Thursday morning, rising 1.25% to 1,372.71 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and biopharmaceutical company Genfit , which climbed 7.3% and 4.1% respectively. They were followed by pharmaceutical company Sanofi  and electronics conglomerate Philips , which were up 3.4% and 2.6% respectively.The decliners from continental Europe were led by biotech firm Evaxion Biotech  and accommodations booking company trivago , which fell 27.7% and 2.5% respectively. They were followed by biopharmaceutical company DBV Technologies  and medical device maker EDAP , which were down 1.5% each.From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma  and Prudential , which rose 4.1% and 3.5% respectively. They were followed by educational publisher Pearson  and oil and gas company Shell , which increased 3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765646.SGD","BK4585","BK4007","BK4588","EDAP","PUK","LU0098860793.USD","BK4162","BK4139","TRIB","LU0300736062.USD","BK4204","PHG","BK4107","BK4547","VRNA","MREO","AFG","BK4111","TRVG","BK4505","BK4020","LU1162221912.USD","LU2236285917.USD","IE00BMPRXN33.USD","GNFT","BK4201","LU0300736492.USD","PSO","SHEL","DBVT","BK4082","EVAX","LU0278409577.USD","BK4117","NOK","NCNA","IE00BMPRXR70.SGD","SNY","IE00BFXG1179.USD","BK4077"],"gpt_icon":1},{"id":"2507235896","title":"Evaxion Biotech Announces $10.8 Million Public Offering to Advance Vaccine Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2507235896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507235896?lang=en_us&edition=fundamental","pubTime":"2025-01-30 21:28","pubTimestamp":1738243682,"startTime":"0","endTime":"0","summary":"Evaxion Biotech ( ($EVAX) ) has provided an update. On January 30, 2025, Evaxion Biotech announced the pricing of a $10.8 million public offering o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-announces-10-8-million-public-offering-to-advance-vaccine-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-announces-10-8-million-public-offering-to-advance-vaccine-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.2432},{"period":"3month","weight":-0.6542},{"period":"6month","weight":-0.8451},{"period":"1year","weight":-0.88},{"period":"ytd","weight":-0.4109}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.307156},{"month":2,"riseRate":0.25,"avgChangeRate":-0.036259},{"month":3,"riseRate":0,"avgChangeRate":-0.133841},{"month":4,"riseRate":0.75,"avgChangeRate":0.137684},{"month":5,"riseRate":0.25,"avgChangeRate":-0.067063},{"month":6,"riseRate":0.25,"avgChangeRate":-0.055002},{"month":7,"riseRate":0.25,"avgChangeRate":0.052601},{"month":8,"riseRate":0.5,"avgChangeRate":-0.067943},{"month":9,"riseRate":1,"avgChangeRate":0.154645},{"month":10,"riseRate":0.25,"avgChangeRate":-0.004732},{"month":11,"riseRate":0,"avgChangeRate":-0.303517},{"month":12,"riseRate":0,"avgChangeRate":-0.217452}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction